Cargando…

Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2

Introduction: The objective of this study was to evaluate the clinical and laboratory outcomes of solid cancer patients who were reinfected with COVID-19. Methods: Patients who were tested negative on the Coronavirus disease 2019 (COVID-19) PCR test and those with improved clinical conditions after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ünsal, Oktay, Yazıcı, Ozan, Özdemir, Nuriye, Çubukçu, Erdem, Ocak, Birol, Üner, Aytuğ, Özet, Ahmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628862/ https://www.ncbi.nlm.nih.gov/pubmed/34825831 http://dx.doi.org/10.2217/fon-2021-0621

Ejemplares similares

1568P Clinical and laboratory outcomes of solid cancer patients reinfected with SARS-CoV-2
por: Yazıcı, O., et al.
Publicado: (2021)

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma
por: Aslan, Volkan, et al.
Publicado: (2023)

510P Long-term outcomes of COVID-19 infection in patients with solid tumors before vaccination
por: Yazici, O., et al.
Publicado: (2022)

The possible relation between temporal muscle mass and glioblastoma multiforme prognosis via sarcopenia perspective
por: SÜTCÜOĞLU, Osman, et al.
Publicado: (2022)

Efficacy of chemotherapeutics on classic and non-classic Kaposi sarcoma: a single-center retrospective real-world study
por: Orhan, Sibel Oyucu, et al.
Publicado: (2021)

Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
por: GÜRLER, Fatih, et al.
Publicado: (2022)

SARS-CoV-2 reinfection or persistence among immunodeficient patients
por: Özdemir, Öner
Publicado: (2023)

Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection
por: Murillo-Zamora, E., et al.
Publicado: (2021)

Analysis of Turkish Breast Cancer Patients With ATM-Heterozygous Germline Mutation According to Clinicopathological Features
por: Ünsal, Oktay, et al.
Publicado: (2023)

The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans
por: Deligönül, Adem, et al.
Publicado: (2021)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

Laboratory-conﬁrmed SARS-CoV-2 reinfection in the population treated at social security
por: Santiago-Espinosa, Oscar, et al.
Publicado: (2021)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

Reinfection With SARS-CoV-2: Implications for Vaccines
por: Cohen, Jeffrey I, et al.
Publicado: (2020)

Serological Markers of SARS-CoV-2 Reinfection
por: Siddiqui, Sameed M., et al.
Publicado: (2022)

Reinfection with SARS-CoV-2: An inconvenient truth?
por: Sonié, Pedro, et al.
Publicado: (2022)

Epidemiological assessment of SARS-CoV-2 reinfection
por: Almadhi, Marwa, et al.
Publicado: (2022)

Reinfection, recontamination and revaccination for SARS-CoV-2
por: Kullmann, Tamás, et al.
Publicado: (2022)

Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient
por: Klein, Jon, et al.
Publicado: (2021)

A case of SARS-CoV-2 reinfection in Ecuador
por: Prado-Vivar, Belén, et al.
Publicado: (2021)

The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
por: Babiker, Ahmed, et al.
Publicado: (2021)

SARS-CoV-2 reinfection and COVID-19 severity
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer
por: Bozkaya, Yakup, et al.
Publicado: (2018)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

A case with SARS-CoV-2 reinfection from India
por: Munivenkatappa, Ashok, et al.
Publicado: (2022)

An immune correlate of SARS-CoV-2 infection and severity of reinfections
por: Maier, Hannah E., et al.
Publicado: (2021)

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

High rate of reinfection with the SARS-CoV-2 Omicron variant
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Genomic evidence of SARS‐CoV‐2 reinfection in the Republic of Korea
por: Park, Ae Kyung, et al.
Publicado: (2021)

Persistence and viability of SARS-CoV-2 in primary infection and reinfections
por: Ruiz-Galiana, Julián, et al.
Publicado: (2021)

Viable virus shedding during SARS-CoV-2 reinfection
por: Letizia, Andrew G, et al.
Publicado: (2021)

Reinfections with SARS-CoV-2 or second COVID-19 episodes?
por: Cabrera-Gaytán, David Alejandro, et al.
Publicado: (2021)

Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 Reinfection
por: Comba, Isin Yagmur, et al.
Publicado: (2022)

Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador
por: Guevara, Rommel, et al.
Publicado: (2022)

Reinfections with Different SARS-CoV-2 Omicron Subvariants, France
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Infectivity of SARS-CoV-2 and protection against reinfection in rats
por: Yu, Dandan, et al.
Publicado: (2022)

SARS-CoV-2 reinfections during the Delta and Omicron waves
por: Morris, C. Paul, et al.
Publicado: (2022)

Patterns of reported infection and reinfection of SARS-CoV-2 in England
por: Keeling, Matt J.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_spna1uhsjod8kt93hg6nu2vnvg